Thursday, 28 January 2021

Eyewear Market to Reflect a Holistic Expansion During 2021 to 2028

 Eyewear Market Growth & Trends

The global eyewear market size is anticipated to reach USD 278.95 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to exhibit a CAGR of 8.5% during the forecast period. Advancements in lens-making technology enable eyewear manufacturers to produce large quantities of eye lenses, thus providing users with more affordable and diverse buying options. The integration of 3D printing technology with the eyewear manufacturing process further offers eyewear providers the opportunity to exercise efficient resource management and mitigate costs associated with extensive inventories, limited product design, and complicated supply chains.

The rising demand for customized eyewear among users is fueling the market growth. People prefer unique products that are tailored according to their needs, such as the shape of eyes and face, color and texture of glasses, and the frame's design and material. This is expected to result in the disruption of distribution models to meet end-users' demands, thus offering market growth opportunities over the next few years. To cater to this trend, an increasing number of eyewear manufacturers, such as Topology and Pair Eyewear, have started offering customized eyewear to their customers. These customized eyewear products include glasses with different features, such as eliminating UV radiation, photochromic glasses, and glasses with a high index number.

The amalgamation of digital channels with the eyewear value chain in recent years has increased the sales of eyewear products significantly. The e-commerce distribution channel is gradually gaining momentum due to the ongoing COVID-19 pandemic, which encourages users to practice social distancing and order from their homes. Several eyewear companies, including Lenskart, are offering users the opportunity to make calculated spectacle buying decisions by providing virtual facial analysis and product virtualization facilities. Additionally, establishing digital channels allows companies to maintain essential customer data such as their buying preferences, search history, and feedback, which can help them offer more curated and specific products to their customers in the future.

The emerging demand to practice sustainability among eyewear companies and their customers is changing the market dynamics. Eyewear manufacturers such as Evergreen Eyecare and Modo have started using eco-friendly materials in eyewear designs, which helps the company practice sustainable development and enhance its customer journey. The trend is encouraging newer eyewear manufacturers such as Shwood Eyewear and PaperStyle to diversify their products and offer more ecological, budget-friendly, and unique products to customers while also capture a better revenue share. Companies are experimenting with materials such as wood, paper, leather, and wool to design eyewear with innovative textures, which promises to attract more customers.

Request a free sample copy or view report summary: Eyewear Market Report

Eyewear Market Report Highlights

  • In terms of product, the sunglasses segment is expected to emerge as the fastest-growing segment over the forecast period. The promising growth prospects of the segment can be attributed to the gradual easing of travel restrictions, which is promoting people to use sunglasses as a travel accessory.
  • In terms of the distribution channel, the e-commerce segment is envisioned to register the highest growth rate over the forecast period. This can be attributed to the better functionality, ease of access, better discounts, and better buying options offered by online players.
  • The Asia Pacific region is expected to register the highest CAGR over the forecast period. This can be chiefly attributed to the resumption of eyewear and eyewear parts manufacturing and essential supply chain activities in China, which is a major supplier of eyewear parts in the world.
  • The growing demand for colored contact lenses and increasing penetration of soft contact lenses in Japan and China is further promoting the demand for eyewear in the Asia Pacific region.
  • In response to the COVID-19 pandemic, companies rapidly deployed their IT capabilities to execute remote connections with employees and customers to deliver a productive and functional, and productive Work From Home (WFH) strategy, which has kept the market buoyant.

Eyewear Market Segmentation

Grand View Research has segmented the global eyewear market based on product, distribution channel, and region:

Eyewear Product Outlook (Volume, Million Units; Revenue, USD Million, 2017 - 2028)

  • Contact Lenses
    • Premium Contact Lenses
    • Mass Contact Lenses
  • Spectacles
    • Spectacle Frame
      • Type
        • Premium Spectacle Frames
        • Mass Spectacle Frames
      • Style
        • Round
        • Square
        • Rectangle
        • Oval
        • Others
      • Spectacle Lenses
    • Sunglasses
      • Lens Type
        • Polarized Sunglasses
        • Non-Polarized Sunglasses
      • Lens Material
        • CR-39
        • Polycarbonate
        • Polyurethane
        • Others

Eyewear Distribution Channel Outlook (Revenue, USD Million, 2017 - 2028)

  • E-Commerce
  • Brick& Mortar

Eyewear Regional Outlook (Volume, Million Units; Revenue, USD Million, 2017 - 2028)

  • North America
    • US.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK.
  • Asia Pacific
    • China
    • India
    • Japan
    • Vietnam
  • South America
    • Brazil
  • MEA

List of Key Players in the Eyewear Market

  • Johnson & Johnson Vision Care, Inc.
  • ESSILORLUXOTTICA
  • CooperVision
  • Carl Zeiss AG.
  • Bausch & Lomb Inc.
  • Safilo Group S.p.A.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Wednesday, 27 January 2021

Biopharmaceutical CMO And CRO Market Growth Factors, Demand, Opportunities, Current Trends & Predictions

 Biopharmaceutical CMO & CRO Market Growth & Trends

The global biopharmaceutical CMO and CRO market size is expected to reach USD 49.2 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 7.6% from 2021 to 2028. The market is significantly driven by the growing interest of conventional drug developers in biological therapeutics. At present, outsourcing has become a cost-saving strategy for small to medium-sized bio-manufacturers as it helps in eliminating the need for establishing costly specialized facilities or hiring and training personnel.

The global market for biopharmaceutical CMO and CRO is expected to thrive during the pandemic owing to positive pipeline development across modalities. For instance, Lonza and Moderna announced a ten-year collaboration for the commercial manufacturing of the COVID-19 vaccine. Such developments compensated for minor delays in clinical trials that occurred during the first half of 2020. The contract manufacturing organization segment is projected to unlock lucrative growth opportunities over the foreseeable future.

The decline in R&D productivity and increased development costs have resulted in high pressure on biopharmaceutical manufacturers pertaining to short-term earnings and profit margins. This, in turn, has created lucrative opportunities for the CMOs and CROs to accelerate their business operations.

The mammalian source segment dominated the market in 2020. CMOs are engaged in standardizing their mammalian systems, thereby driving the revenue growth in the mammalian segment. Plant-based expression systems are developed and explored as a cost-effective alternative for the production of large molecules.

The robustness of venture capital investments is one of the important supportive factors that has created opportunities for the growth of CMOs. Venture capital funds are considered more reliable than public equity. An increase in the availability of venture funds for life sciences is expected to bolster the growth of CMOs.

However, these CMOs and CROs are facing competition from in-house departments of pharmaceutical and biotechnology companies. Several big pharma companies like Novartis announced to keep their biomanufacturing process in-house.

Some key CMOs are Lonza; Boehringer Ingelheim GmbH; Patheon; Samsung BioLogics; and FUJIFILM Diosynth Biotechnologies U.S.A., Inc. The key players are involved in establishing mutually beneficial alliances with other emerging CMOs to scale up their production capabilities.

Request a free sample copy or view report summary: Biopharmaceutical CMO & CRO Market Report

Biopharmaceutical CMO & CRO Market Report Highlights

  • Based on source, mammalian cell line-based bioproduction system accounted for the largest revenue share of 54.0% in 2020 due to the growth in mammalian system titers and yields
  • By service type, contract manufacturing services accounted for the largest share of 57.7% in 2020 owing to the presence of a wide range of services from cell line development to the final packaging of the product
  • Contract research services are expected to expand at the fastest CAGR of 8.4% over the forecast period. This can be attributed to increasing investment in research programs for the development of novel therapeutics
  • In terms of product, biologics held the largest share of 81.8% in 2020. In recent times, biologics manufacturing is becoming more specialized, as a result of which CMOs have become an integral part of the biologics production strategies of clients
  • North America held the largest share of 33.8% in 2020. The North American biopharmaceutical research industry is recognized as a leader in biopharmaceutical innovations. Several biopharma companies from the U.S. are considering Asian countries for the development of pharma products. This is primarily due to the growing costs of R&D in their home country and the presence of low-cost production facilities and cheap labor in Asian countries

Biopharmaceutical CMO & CRO Market Segmentation

Grand View Research has segmented the global biopharmaceutical CMO and CRO market on the basis of source, service type, product, and region:

Biopharmaceutical CMO & CRO Source Outlook (Revenue, USD Million, 2016 - 2028)

  • Mammalian
  • Non-mammalian

Biopharmaceutical CMO & CRO Service Type Outlook (Revenue, USD Million, 2016 - 2028)

  • Contract Manufacturing
    • Process Development
      • Downstream
      • Upstream
    • Fill & Finish Operations
    • Analytical & QC studies
    • Packaging
  • Contract Research
    • Oncology
    • Inflammation & Immunology
    • Cardiology
    • Neuroscience
    • Others

Biopharmaceutical CMO & CRO Product Outlook (Revenue, USD Million, 2016 - 2028)

  • Biologics
    • Monoclonal antibodies (MABs)
    • Recombinant Proteins
    • Vaccines
    • Antisense, RNAi, & Molecular Therapy
    • Others
  • Biosimilars

Biopharmaceutical CMO & CRO Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • Germany
    • France
  • Asia Pacific
    • China
    • Japan
  • Latin America
    • Brazil
  • Middle East & Africa
    • South Africa

List of Key Players of the Biopharmaceutical CMO & CRO Market

  • Boehringer Ingelheim GmbH
  • Lonza
  • Inno Biologics Sdn Bhd
  • Rentschler Biotechnologie GmbH
  • JRS PHARMA
  • BIOMEVA GmbH
  • ProBioGen
  • FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
  • TOYOBO CO., LTD.
  • Samsung BioLogics

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.    

Fitness App Market to Surpass USD 15.5 Billion by 2028: Grand View Research Inc.

 Fitness App Market Growth & Trends

The global fitness app market size is expected to reach USD 15.5 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 21.6% from 2021 to 2028. Rising health and fitness awareness and the growing prevalence of obesity are major factors driving the global market. According to the Centers for Disease Control and Prevention, the prevalence of obesity increased from 30.5% in 1999-2000 to 42.4% in 2017-2018. Moreover, awareness regarding obesity-related health conditions, including diabetes, stroke, heart diseases, and cancer, is increasing. This, in turn, is fueling the adoption of fitness apps to manage weight and aid weight loss.

The lockdown and social distancing norms by governments to control the spread of the COVID-19 virus have negatively impacted the gyms and fitness centers globally. However, consumers have shifted their focus to online fitness classes and apps. The total number of downloads and active users increased rapidly during the COVID-19 lockdown. For instance, the daily active users on fitness apps increased by 24% in Asia Pacific, 11% in Europe, 8% in Americas, and 28% in the Middle East and North Africa between quarter 1 and quarter 2 of 2020. Moreover, many fitness apps are witnessing an increase in their downloads and profits. For instance, HealthifyMe, an Indian fitness app, witnessed a 30% increase in traffic and a 40% increase in revenue in April 2020.

Moreover, a rise in the number of product launches, investments, collaborations, partnerships, and mergers & acquisitions is boosting the adoption of fitness apps in the market. For instance, in March 2020, Curefit, a health and fitness company, received USD 110 million in funding from Temasek Holdings Limited. In November 2020, Hong Kong Baptist University (HKBU) and The Chinese University of Hong Kong (CUHK) collaborated to launch MusFit Action Mobile App, which is focused on home-based exercises for elderly and middle-aged people. In December 2020, National Football League player DeMarcus Ware introduced his fitness app Driven to Win on Apple Store. The subscribers can work out with NBL players through this app. This app will be available for Android from 2021.

Request a free sample copy or view report summary: Fitness App Market Report

Fitness App Market Report Highlights

  • The exercise and weight loss segment emerged as the leading type segment in 2020 with a revenue share of 54.7%
  • By platform, iOS accounted for the largest revenue share in 2020. The Android segment is projected to expand at the fastest CAGR during the forecast period
  • Based on the device, smartphones accounted for the largest revenue share in 2020. Wearable devices are projected to expand at the fastest CAGR during the forecast period
  • North America accounted for the largest share in 2020 due to the increasing awareness regarding health and wellness, high penetration of smartphones, and availability of a large number of fitness apps

Fitness App Market Segmentation

Grand View Research has segmented the global fitness app market on the basis of type, platform, device, and region:

Fitness App Type Outlook (Revenue, USD Million, 2016 - 2028)

  • Exercise & Weight Loss
  • Diet & Nutrition
  • Activity Tracking

Fitness App Platform Outlook (Revenue, USD Million, 2016 - 2028)

  • Android
  • iOS
  • Others

Fitness App Device Outlook (Revenue, USD Million, 2016 - 2028)

  • Smartphones
  • Tablets
  • Wearable Devices

Fitness App Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • UK.
    • Germany
    • France
    • Italy
    • Spain
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
  • Latin America
    • Mexico
    • Brazil
  • Middle East & Africa
    • South Africa

List of Key Players of Fitness App Market

  • Adidas
  • Fitbit, Inc.
  • Appster
  • Azumio, Inc.
  • MyFitnessPal Inc.
  • Applico
  • FitnessKeeper
  • Aaptiv
  • Nike
  • Noom
  • Under Armour, Inc.
  • Appinventiv

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Custom T-shirt Printing Market To Make Great Impact In The Near Future by 2028: Grand View Research Inc.

 Custom T-shirt Printing Market Growth & Trends

The global custom t-shirt printing market size is anticipated to reach USD 7.57 billion by 2028, according to a new report by Grand View Research, Inc. It is projected to register a CAGR of 9.7% from 2021 to 2028. Increasing preference towards fashionable, customized, and unique clothing, as well as rising disposable income within the young population, are major factors driving demand for custom t-shirts worldwide. Customized t-shirts are primarily targeted toward the young population as it allows them to design clothing matching their style, personality, and preference.

Customized sportswear and trendy gym clothes are becoming more popular as people are getting into the athleisure trend. Sports teams and clubs of almost all the sports worldwide have started wearing custom designed jerseys and t-shirts with their unique logo and design. Every sporting club is nowadays following the trend to provide a unique appearance to their team players and increase their team's visibility. Sports-related activities across countries such as Germany, China, and India are witnessing significant growth with increasing investments by governments of these countries on sporting activities. As a result, the demand for custom printed t-shirts is expected to increase in the forthcoming years.

Customized t-shirts are printed using several techniques, including screen print, digital print, and plot print. The screen printing technique uses a predesigned stencil to develop the print on the cloth and is one of the most popular techniques. Furthermore, this technique requires a high use of labor. This technique has been observed to have high adoption in the Asia Pacific region due to low-cost labor availability.

Request a free sample copy or view report summary: Custom T-shirt Printing Market Report

Custom T-shirt Printing Market Report Highlights

  • The market for custom t-shirt printing is anticipated to witness substantial growth during the forecast period due to the increasing use of customized t-shirts for the promotion of a brand, company, movie, sports team, or league, among others
  • The screen printing segment accounted for the largest revenue share in 2020 owing to the high color vibrancy provided by this technique
  • The digital printing segment is expected to register the highest CAGR over the forecast period owing to lesser time and efforts involved in the process
  • The graphic designed shirts segment accounted for the largest revenue share in 2020 owing to the high demand for t-shirts with pre-printed graphics
  • Asia Pacific accounted for the largest revenue share, followed by Europe, in 2020, owing to the presence of numerous market players and high proliferation of the e-commerceindustry in the region
  • Some of the prominent market players in the market include Vistaprint; THREADBIRD; Printful Inc.; and CafePress, Inc.

Custom T-shirt Printing Market Segmentation

Grand View Research has segmented the global custom t-shirt printing market based on printing technique, design, and region:

Printing Technique Outlook (Revenue, USD Billion, 2016 - 2028)

  • Screen Printing
  • Digital Printing
  • Plot Printing

Design Outlook (Revenue, USD Billion, 2016 - 2028)

  • Graphic Designed Shirt
  • Artwork

Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • UK.
    • Germany
  • Asia Pacific
    • China
    • India
    • Japan
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa

List of Key Players of Custom T-shirt Printing Market

  • CafePress Inc.
  • CustomInk, LLC.
  • CustomThread
  • Printful Inc.
  • com
  • Spreadshirt
  • THEBLUEGECKOPRINTING
  • THREADBIRD
  • UberPrints, Inc.
  • Vistaprint

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Healthcare Additive Manufacturing Market Is Expected To Accomplish A Valuation Of Around USD 6.4 Billion By 2028

 Healthcare Additive Manufacturing Market Growth & Trends

The global healthcare additive manufacturing market size is valued at USD 6.4 billion in 2028 and is anticipated to grow at a CAGR of 21.8% over the forecast period, according to a new report by Grand View Research, Inc. Easy development of customized products, reduction in manufacturing cost due to technological advancements, and possibilities of using various material for printing are propelling the market growth.

The growing success of additive manufacturing is due to its benefits over conventional manufacturing methods. Some of the benefits include the application of advanced technology; use of a wide range of materials like metal, plastics, and polymers; flexibility in design; build speed; dimensional accuracy; and its ability to produce complex parts/geometry, such as cooling channels and honeycomb structure. Production of implants and prosthetics is the largest application for additive manufacturing in the healthcare industry.

There is an increasing demand for orthopedic procedures, such as knee & hip replacements, due to the increasing geriatric population. Moreover, the increasing application of dental implants along with a growing need for prosthetics is another key factor expected to drive the market. North America and Europe were the leading regional markets in 2020. This growth was attributed to extensive R&D, advanced healthcare system, and the presence of leading 3D printing machinery manufacturers & material suppliers in these regions.

Additive manufacturing is playing a significant role in the fight against COVID-19 by compensating for the shortage of medical supplies by speeding up the manufacturing process. This will drive the growth of the market over the forecast period. However, stringent regulatory approvals associated with medical devices might hinder the growth.

Request a free sample copy or view report summary: Healthcare Additive Manufacturing Market Report

Healthcare Additive Manufacturing Market Report Highlights

  • Laser sintering accounted for the largest market share of 31.0% in 2020 as it uses a wide variety of materials to make high-quality, complex geometries and can produce several pieces at one time
  • The polymers material segment accounted for the largest revenue share of more than 50% in 2020, as polymer-based AM has been used for decades in creating medical instruments as well as prosthetic limbs & related accessories
  • North America led the market in 2020 and accounted for the largest share of more than 35% due to the presence of several additive manufacturing companies with a robust distribution network
  • Asia Pacific is projected to be the fastest-growing regional market over the forecast period due to significant demand for dental 3D printingas a result of an increasing number of people undergoing tooth replacement surgeries

Healthcare Additive Manufacturing Market Segmentation

Grand View Research has segmented the global healthcare additive manufacturing market on the basis of technology, application, material, and region:

Healthcare Additive Manufacturing Technology Outlook (Revenue, USD Million, 2016 - 2028)

  • Stereolithography
  • Deposition Modeling
  • Electron Beam Melting
  • Laser Sintering
  • Jetting Technology
  • Laminated Object Manufacturing
  • Others

Healthcare Additive Manufacturing Application Outlook (Revenue, USD Million, 2016 - 2028)

  • Medical Implants
  • Prosthetics
  • Wearable Devices
  • Tissue Engineering
  • Others

Healthcare Additive Manufacturing Material Outlook (Revenue, USD Million, 2016 - 2028)

  • Metals & Alloys
  • Polymers
  • Biological Cells
  • Others

Healthcare Additive Manufacturing Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • UK.
    • Germany
    • Spain
    • France
    • Italy
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

List of Key Players of Healthcare Additive Manufacturing Market

  • GE Additive (General Electric)
  • 3D Systems, Inc.
  • EnvisionTEC GmbH
  • RegenHU
  • Allevi, Inc.
  • EOS GmbH (Electro Optical Systems)
  • Materialise N.V.
  • Stratasys Ltd.
  • Nanoscribe GmbH
  • GPI Prototype and Manufacturing Services, LLC

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Clinical Trial Imaging Market Latest Trends, Industry Growth And Forecast To 2028: Grand View Research Inc.

 Clinical Trial Imaging Market Growth & Trends

The global clinical trial imaging market size is expected to reach USD 1.4 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 6.1% from 2021 to 2028. The increasing R&D spending to develop new drugs and therapies to treat chronic diseases is propelling the market growth.

Clinical trial imaging makes use of imaging technology in clinical trials for seeing the interior parts of the body. The images obtained from clinical trial imaging are used to examine drug activity. Clinical trial imaging provides rapid, detail, and precise screening. The use of clinical trial imaging has rapidly increased in all phases of the clinical trials. Medical imaging in clinical trials is used as a primary, quantitative, and surrogate biomarker.

The clinical trial design includes selecting patient population, stratification based on biomarkers, different methods for allocation treatments, choosing efficient and reliable endpoints and validation of surrogate endpoints, calculating sample size, trial simulations, adaptive trial set-up, statistical and interim analysis, and assisting clients to deal with regulatory authorities, such as EMA and FDA, to discuss study design or defend study results.

Market players provide analytical testing services, pharmacokinetic, reading, and pharmacodynamics services for enhanced clinical development. IXICO offers advanced technologies for catalyzing clinical trials in neuroscience. Imaging biomarkers by the company help in measuring the safety and effectiveness of therapies used for neuroimaging. Imaging biomarkers are effective in radiological reads. This provides a radiological reading of MRI scans for central neuro to enhance the assessment of ongoing monitoring of drug safety and subject eligibility.

Request a free sample copy or view report summary: Clinical Trial Imaging Market Report

Clinical Trial Imaging Market Report Highlights

  • Based on service, project and data management services held the largest share in 2020 due to the growing requirement of data management and workflow for clinical trial imaging
  • Operational imaging services held a significant share in 2020. They include imaging modalities such as MRI, CT scan, X-ray, ultrasound, OCT, PET, and SPECT. CT scan modality is gaining popularity due to its non-invasive nature and its ability to provide detailed information about the disease for enhanced treatment
  • The others application segment held the largest share in 2020. This segment includes oncology, neurology, and musculoskeletal. Market players such as ICON, Bioclinica, Navitas Life Sciences, and Paraxel International are developing their clinical trial imaging services for these applications
  • By end-use, CROs held the largest share in 2020 due to increasing investments in the field of research and development and snowballing outsourcing activities by the pharmaceutical and biotechnology companies to cut down the cost and time and patent expiration
  • North America dominated the market in 2020 due to the increasing geriatric population, rising chronic diseases, and growing demand for treatment options

Clinical Trial Imaging Market Segmentation

Grand View Research has segmented the global clinical trial imaging market based on service, application, end-use, and region:

Clinical Trial Imaging Service Outlook (Revenue, USD Million, 2016 - 2028)  

  • Clinical Trial Design and Consultation Services
  • Reading and Analytical Services
  • Operational Imaging Services
    • Computed Tomography (CT) Scan
    • MRI (Magnetic Resonance Imaging)
    • X-Ray
    • Ultrasound
    • Optical Coherence Tomography (OCT)
    • Others
  • System and Technology Support Services
  • Project and Data Management

Clinical Trial Imaging Application Outlook (Revenue, USD Million, 2016 - 2028)      

  • NASH
  • CKD
  • Diabetes
  • Cardiovascular Diseases
  • Others

Clinical Trial Imaging End-use Outlook (Revenue, USD Million, 2016 - 2028)

  • Biotechnology and Pharmaceutical companies
  • Medical Devices Manufacturers
  • Academic and Government Research Institutes
  • Contract Research Organizations (CROs)
  • Others

Clinical Trial Imaging Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • UK.
    • Germany
    • France
    • Italy
    • Spain
  • Asia Pacific
    • India
    • China
    • Japan
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

List of Key Players of Clinical Trial Imaging Market

  • Parexel International Corporation
  • Intrinsic Imaging
  • Bioclinica Inc.
  • Icon PLC
  • Radiant Sage
  • Navitas Life Sciences
  • Resonance Health
  • IXICO PLC
  • Medpace

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Medical Foods Market To Hold a High Potential for Growth by 2028

 Medical Foods Market Growth & Trends

The global medical foods market size is anticipated to reach USD 30.34 billion by 2028 according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.2% over the forecast period. Factors such as the growing prevalence of chronic conditions along with the increasing geriatric population adopting medical foods are positively impacting the growth. Rising awareness regarding clinical nutrition among healthcare professionals and patients is projected to further bolster the growth over the forecast period.

Based on the route of administration, oral administration dominated the market in 2020. Factors contributing to the high share include high commercial viability of orally administered products and high preference for orally administered medical foods owing to ease in consumption. Oral supplements are available in various forms such as powders, pills, puddings, and pre-thickened products, thereby propelling the overall growth.

In 2020, based on product type, the others segment accounted for the highest revenue share. The others' segment comprises of liquid, semi-liquid, and semi-solid products. This growth is attributed to increasing application areas of medical foods, high commercial availability, and easy administration of these products. Owing to ease of consumption, liquid formulations are preferred by geriatric as well as pediatric populations, thereby increasing its overall revenue share.

Based on application, diabetic neuropathy dominated the market share in 2020. Rising diabetes prevalence and an increase in the number of patients that are at risk of developing some level of neuropathy are some of the factors boosting the overall growth. For instance, according to Healthline, around 60% to 70% of people suffering from diabetes have some or other form of neuropathy. The risk of suffering from neuropathy increases with an aging, unhealthy lifestyle, and change in diet which leads to an increased focus on nutritional management, thereby fueling the growth.

In 2020, based on sales channels, institutional sales accounted for the highest revenue share. This share is attributable to higher adoption and consumption of enteral and oral medical foods in healthcare institutions such as hospitals, clinics, and care centers. There is an increase in demand for such products in inpatient facilities. Hence, rising demand and consumption of these products under medical supervision are some of the factors contributing to the growth of the segment.

North America dominated the market with a revenue share of 29.9% in 2020 owing to the presence of key market players and high revenue generated by these players in this region. Strategic initiatives by players, increasing prevalence of chronic conditions, and rising adoption of medical foods by healthcare professionals and patients are other factors supporting the regional market growth.

Request a free sample copy or view report summary: Medical Foods Market Report

Medical Foods Market Report Highlights

  • The oral segment accounted for the highest revenue share in 2020, owing to the high commercial viability of orally administered products and high preference for orally administered medical foods
  • The others' segment dominated the market in 2020, owing to increasing application areas, high commercial availability, and easy administration of the products
  • Diabetic Neuropathy dominated the market in 2020, owing to increasing diabetes prevalence and the rising number of patients that are at risk of developing some level of neuropathy
  • Institutional sales accounted for the highest revenue share in 2020, owing to higher adoption and consumption of enteral and oral medical foods in healthcare institutions such as hospitals, clinics, and care centers
  • North America dominated the market with a revenue share of 29.9% in 2020, owing to the presence of key market players and high revenue generated by these players in this region

Medical Foods Market Segmentation

Grand View Research has segmented the global medical foods market based on the route of administration, product, application, sales channel, and region:

Medical Foods Route of Administration Outlook (Revenue, USD Million, 2014 - 2028)

  • Oral
  • Enteral

Medical Foods Product Outlook (Revenue, USD Million, 2014 - 2028)

  • Pills
  • Powder
  • Others

Medical Foods Application Outlook (Revenue, USD Million, 2014 - 2028)

  • Chronic Kidney Disease
  • Minimal Hepatic Encephalopathy
  • Chemotherapy-induced Diarrhea
  • Pathogen Related Infections
  • Diabetic Neuropathy
  • ADHD
  • Depression
  • Alzheimer's Disease
  • Nutritional Deficiency
  • Orphan Diseases
    • Phenylketonuria
    • Eosinophilic Esophagitis
    • FPIES
    • Others
  • Other 

Medical Foods Sales Channel Outlook (Revenue, USD Million, 2014 - 2028)

  • Online Sales
  • Retail Sales
  • Institutional Sales

Medical Foods Regional Outlook (Revenue, USD Million, 2014 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • UK.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
  • Asia-Pacific
    • Australia
    • China
    • Japan
    • South Korea
    • India
    • New Zealand
    • Singapore
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East Africa
    • South Africa
    • Saudi Arabia
    • UAE

List of Key Players of Medical Foods Market

  • Danone
  • Nestle Nutrition
  • Abbott Nutrition
  • Targeted Medical Pharma, Inc.
  • Primus Pharmaceuticals, Inc.
  • Mead Johnson & Company, LLC.
  • Medtrition, Inc.
  • Fresenius Kabi AG

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

In Vitro Diagnostics Market Growth in the Coming Years

 In Vitro Diagnostics Market Growth & Trends

The global in vitro diagnostics market size is expected to reach USD 113.9 billion by 2027, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 4.5% from 2021 to 2027. The growth is driven by the growing geriatric population and technological advancements in diagnostics that are supporting its adoption.

Technological advancements in terms of accuracy, portability, and cost-effectiveness are expected to be one of the high impact rendering drivers of this market. For instance, in June 2017, Agena Bioscience launched the MassARRAY system integrated with CHIP Prep Module in Europe. The system was marketed as a CE-IVD product under Directive 98/79/EC. Moreover, Real-Time Polymerase Chain Reaction (qPCR) is one of the fastest-growing application segments of the in vitro diagnostics (IVD) market.

The IVD market is highly competitive in nature. Consequently, manufacturers are required to improvise products in terms of specificity, accuracy, precision, speed, and other parameters, in order to gain an advantage over previously marketed products.

A steady rise in consumer awareness about diagnosing infectious diseases and increasing disease prevalence, especially in developing and under-developed countries, are driving the market penetration of the products. For instance, in February 2019, Abbott received CE Mark for DETERMINE HBSAG 2 test for detection and diagnosis of hepatitis B surface antigen.

Organizations promote funding to support R&D and product development exercises pertaining to clinical diagnostics. For instance, Vela Diagnostics received USD 225,000 as Biomedical Advanced Research and Development Authority (BARDA) fund to develop COVID-19 tests. Moreover, the introduction of the American Health Care Act of 2017 is expected to improve the healthcare of the U.S. Rising government initiatives pertaining to the importance of IVD will fuel market growth.

The presence of effective technologies such as molecular diagnostics is expected to reduce the threat of substitutes. Moreover, their contribution in the field of genetic testing is of paramount importance and, therefore, experience a low threat of substitutes. However, high prices of these tests are expected to encourage patients to shift to external substitutes.

Major players in the market are Roche Diagnostics; Becton Dickinson; Abbott Laboratories; Siemens; and bioMerieux, which are well-established. Therefore, local companies and new organizations have little scope to enter the market and ensure sustainability. However, companies such as Danaher Corporation and Hologic have successfully excelled in the market through mergers and acquisitions. The seed capital required is high.

Request a free sample copy or view report summary: In Vitro Diagnostics Market Report

In Vitro Diagnostics Market Report Highlights

  • Molecular diagnostics is expected to witness the fastest growth over the forecast period
  • High use of reagents in IVD testing, high demand for over-the-counter diagnostic tests, and increase in adoption of these tests in nonmedical facilities, such as home, are some of the factors that are driving the growth, providing it a clinical advantage over other IVD tests
  • Reagents held the largest market share in 2020 owing to the increasing demand for genetic testing and availability of technologically advanced cancer diagnostic tests in countries with unmet clinical needs, such as India and Middle East & Africa
  • The growing availability of CE-IVD certified kits globally to diagnose and screen patients during epidemic situations is expected to boost the growth of reagents and instruments segments
  • Key players are updating their range of testing options for qPCR instruments by undertaking R&D initiatives for the development of kits that target emerging diseases, or by entering into agreements with other kit manufacturing companies

In Vitro Diagnostics Market Segmentation

Grand View Research has segmented the global in-vitro diagnostics market based on the product, technology, application, end-use, and region:

In Vitro Diagnostics Product Outlook (Revenue, USD Million, 2016 - 2027)

  • Instruments
  • Reagents
  • Services

In Vitro Diagnostics Technology Outlook (Revenue, USD Million, 2016 - 2027)

  • Immunoassay
    • Instruments
    • Reagents
    • Services
  • Hematology
    • Instruments
    • Reagents
    • Services
  • Clinical Chemistry
    • Instruments
    • Reagents
    • Services
  • Molecular Diagnostics
    • Instruments
    • Reagents
    • Services
  • Coagulation
    • Instruments
    • Reagents
    • Services
  • Microbiology
    • Instruments
    • Reagents
    • Services
  • Others
    • Instruments
    • Reagents
    • Services

In Vitro Diagnostics Application Outlook (Revenue, USD Million, 2016 - 2027)

  • Infectious Disease
  • Diabetes
  • Oncology
  • Cardiology
  • Nephrology
  • Autoimmune Disease
  • Drug testing
  • Others

In Vitro Diagnostics End-use Outlook (Revenue, USD Million, 2016 - 2027)

  • Hospitals
  • Laboratories
  • Home Care
  • Others

In Vitro Diagnostics Regional Outlook (Revenue, USD Million, 2016 - 2027)

  • North America
    • US.
    • Canada
  • Europe
    • UK.
    • Germany
    • France
    • Italy
    • Spain
    • Russia
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Singapore
    • Australia
  • Latin America
    • Brazil
    • Argentina
    • Mexico
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

List of Key Players of In Vitro Diagnostics Market

  • Abbott
  • Danaher
  • bioMérieux SA
  • Bio-Rad Laboratories, Inc.
  • Becton, Dickinson and Company
  • Siemens Healthineers AG
  • QIAGEN
  • Quidel Corporation
  • Hoffmann-La Roche AG
  • Sysmex Corporation
  • Charles River Laboratories International, Inc.
  • Quest Diagnostics
  • Agilent Technologies

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Thursday, 21 January 2021

Electric Motor Sales Market Factors Hindering The Growth Rate, Challenges and Restraints For Business Development

 Electric Motor Sales Market Growth & Trends

The global electric motor sales market size is expected to reach USD 232.5 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.4% from 2021 to 2028. Rapid technological advancements have been playing an imperative role in the growth of the market. Further, improved insulation and operational efficiency have significantly improved the electro-mechanical machines in terms of safety and functionalities, leading to increased demand across multiple industries. Electric motors are used in multiple applications across industry verticals such as home appliances, industrial machinery, and vehicles. The market is expected to witness high growth from Heating, Ventilation, and Cooling (HVAC) applications as they are an inseparable component of HVAC equipment.

Rising fuel prices across the globe are impelling people to shift to non-conventional fuel alternatives. As a result, electric vehicles are manufactured with a view of reducing operational costs and carbon footprint. The upsurge in the production of electric vehicles is expected to positively impact the demand for electric motors as they are used in various applications ranging from performance components to comfort components of the vehicle.

The industry is characterized by regulatory policies and government initiatives that promote energy efficiency in machines and equipment. High-efficiency and output, low power consumption, increased operational life, and low maintenance costs are essential requirements for the electro-mechanical machines. Notably, technological innovations have introduced improved design, components, and motor specifications resulting in fulfillment of end-user requirements. Innovations and evolving policy frameworks are crucial for industry development and will play a key role in fueling the demand for the products over the forecast period.

Asia Pacific region held the largest revenue share in the electric motor market in 2020 and is projected to witness the fastest CAGR of 7.8% from 2021 to 2028. The growth can be attributed to increasing industrialization investments in countries such as China, India, South Korea, and Australia. Further, the scope for market growth in the region is expected to increase significantly over the coming years, owing to the evolving agriculture sector through efficient irrigation practices and technology transfer.

Request a free sample copy or view report summary: Electric Motor Sales Market Report

Electric Motor Sales Market Report Highlights

  • Increased adoption of the electro-mechanical machines in vehicles, backed by technological advancements resulting in performance enhancement, is expected to positively impact market's growth
  • The AC motor type held the largest share in 2020. It is estimated to generate over USD 166 billion by 2028 due to the extensive use of AC motors in various applications ranging from irrigation pumps to modern-day robotics
  • The fractional horsepower (FHP) output segment represented over 87% of the overall market value in 2020. Fractional horsepower motors are used widely in all household appliances ranging from vacuum cleaners to coffee machines to refrigerators
  • The motor vehicles segment is the most prominent application segment, commanding more than 40.0% of the overall market value in 2020. The electro-mechanical machines are also extensively used in heavy industrial equipment as well as agricultural machinery
  • Asia Pacific will lead the market through 2028, exhibiting a CAGR of 7.8% from 2021 to 2028. The growth of the regional market can be attributed to increasing direct investments in developing nations such as India and China

Electric Motor Sales Market Segmentation

Grand View Research has segmented the global electric motor sales market on motor type, power output, application, and region:

Electric Motor Sales Motor Type Outlook (Revenue, USD Billion, 2016 - 2028)

  • AC
    • Synchronous AC
    • Induction AC
  • DC
    • Brushed DC
    • Brushless DC
  • Hermetic Motor

Electric Motor Sales Power Output Outlook (Revenue, USD Billion, 2016 - 2028)

  • Integral HP Output
  • Fractional HP Output

Electric Motor Sales Application Outlook (Revenue, USD Billion, 2016 - 2028)

  • Industrial Machinery
  • Motor Vehicles
  • HVAC Equipment
  • Aerospace & Transportation
  • Household Appliances
  • Others

Electric Motor Sales Regional Outlook (Revenue, USD Billion, 2016 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • UK.
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
  • Middle East & Africa

List of Key Players of the Electric Motor Sales Market

  • Baldor Electric Company, Inc.
  • Ametek Inc.
  • Franklin Electric Co., Inc.
  • Asmo Co., Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Wheelchair Market to Witness a Pronounce Growth During 2021 – 2028: Grand View Research Inc.

 Wheelchair Market Growth & Trends

The global wheelchair market size is expected to reach USD 4.9 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.0% from 2021 to 2028. The Americans with Disabilities Act (ADA) defines a wheelchair as a manually operated or automated device, designed primarily for use by an individual with a mobility disability. It is mainly used for the purpose of indoor or both indoor and outdoor locomotion. Increase in life span and numbers of elderly persons at a global level is one of the key reasons expected to contribute towards the growth of the market.

The growing integration of automation in healthcare devices, especially mobility devices, such as wheelchairs is a key impacting parameter, projected to support market growth. Wheelchairs today are incorporated with non-linear processing circuits, guide sensors, pulse steering drive, and several controls for making the ride easy and smooth for patients.

Rise in number of disorders requiring a mobility device is also one of the key factors expected to contribute to market growth. One of the common disabilities that require a mobility device is the spinal cord injuries. According to the National Spinal Cord Injury Statistical Center’s Facts and Figures at a Glance 2020, there are around 294,000 people currently living with spinal cord injuries (SCI), in the U.S. with 17,810 new cases each year. Thus, the US is expected to be a key potential market for the manufacturers of the mobility device in the years to come.

The recent COVID-19 pandemic affected the manufacturing and supply chain aspect of the manufacturers to a great extent. Wheelchair services were halted across several countries owing to strict lockdowns being implemented. This had left many wheelchair users in a fix. The manufacturers also faced difficulty since their operations were halted. Although the number of hospital visits by regular patients had reduced during the lockdown, the number of patients affected with COVID-19 witnessed a spike. Thus, demand for the mobility device increased during this period, especially from the hospital segment. With the ease of lockdowns, the manufacturing operation of the mobility device is expected to come back to normal.

Request a free sample copy or view report summary: Wheelchair Market Report

Wheelchair Market Report Highlights

  • The manual product segment led the segment in terms of revenue share in 2020 owing to its increasing use in hospitals. It is also cost-effective and requires little maintenance
  • Rising volume of medical emergencies is a prime factor driving the hospital segment
  • The adults segment was the largest in 2020 in terms of revenue share owing to rise in number of disabilities requiring a mobility device such as the spinal cord injuries and an expanding ageing population
  • North America dominated the market with a revenue share of 35.0% due to increased adoption of advanced technology in wheelchairs and rise in the disabled population

Wheelchair Market Segmentation

Grand View Research has segmented the global wheelchair market based on product, category, application, and region:

Wheelchair Product Outlook (Revenue, USD Million, 2016 - 2028)

  • Manual
  • Electric

Wheelchair Category Outlook (Revenue, USD Million, 2016 - 2028)

  • Adults
  • Pediatric

Wheelchair Application Outlook (Revenue, USD Million, 2016 - 2028)

  • Homecare
  • Hospitals
  • Ambulatory Surgical Centers
  • Rehabilitation Centers

Wheelchair Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • UK.
    • Germany
    • France
    • Italy
    • Spain
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Columbia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

List of Key Players of Wheelchair Market

  • Carex Health Brands, Inc.
  • Drive Medical Design & Manufacturing
  • Graham-Field Health Products Inc.
  • Invacare
  • Medline
  • Sunrise Medical LLC
  • Karman Healthcare
  • Quantum Rehab
  • Numotion
  • Pride Mobility Products Corp.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Dental Equipment Market Competitive Insight and Key Drivers 2021 to 2028: Grand View Research Inc.

 Dental Equipment Market Growth & Trends

The global dental equipment market size is expected to reach USD 16.5 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 12.1% from 2021 to 2028. The market is segmented on the basis of dental radiology equipment, dental lasers, systems and parts, laboratory machines, hygiene maintenance devices, and other equipment. These devices assist in diagnosis, treatment, and maintenance of oral health enabling practitioners to prepare a precise course of treatment.

Companies like Planmeca are constantly bringing in newer computer-aided technology in the market. For instance, in March 2019, the company launched Planmeca Creo C5, which is an advanced 3D printer designed to provide chairside CAD/CAM dentistry and restorative dental practices in a single visit. Drivers like, rising prevalence of oral disorders, the introduction of favorable government initiatives for oral health, and rising medical tourism pertaining to oral procedures are assisting towards the overall market growth.

According to the estimates published by the United Nations in 2019, there were 703 million people aged over 65 years globally, and the number of older individuals is projected to double to 1.5 billion by 2050. The rising prevalence of such oral conditions in the geriatric population is likely to increase the demand for preventive, restorative, and surgical services in the future. According to the American Dental Association, 85.0% of individuals in the United States value oral health and consider it as an essential aspect of overall care. The realization of the importance and maintenance of oral health combined with better access to advanced dental services will help in the growth of the market. However, the “emergency-only” mode of dental care delivery due to the COVID-19 pandemic may have a rippling effect and the market will witness an imminent increase in availing cost of oral care. According to the Journal of Contemporary Dental Practice, dental services may be among the last to relaunch in post-pandemic relaxations since procedures are at high risk of transmission. This might result in serious financial problems and revenue loss for the market.

Request a free sample copy or view report summary: Dental Equipment Market Report

Dental Equipment Market Report Highlights

  • Dental system and parts emerged as the largest product segment in 2020, as these equipment are used for digital imaging and diagnosis of dental ailments
  • The dental lasers segment is expected to witness the highest CAGR during the forecast period, owing to its increasing application in surgical and teeth whitening procedures
  • North America dominated the market in 2020. With the increasing demand for new technologies, a large pool of key players, a rising prevalence of oral disorders, and advanced healthcare infrastructure 
  • Asia Pacific is expected to reciprocate the highest CAGR over the forecast period 

Dental Equipment Market Segmentation

Grand View Research has segmented the global dental equipment market on the basis of product type and region:

Dental Equipment Product Type Outlook (Revenue, USD Million, 2016 - 2028)

  • Dental Radiology Equipment 
    • Intra-Oral
      • Digital X-ray Units
      • Digital Sensors
    • Extra-Oral
      • Digital Units
      • Analog Units
    • Dental Lasers
      • Diode Lasers
        • Quantum well lasers
        • Distributed feedback lasers
        • Vertical cavity surface-emitting lasers
        • Heterostructure lasers
        • Quantum cascade lasers
        • Separate confinement heterostructure lasers
        • Vertical external-cavity surface-emitting lasers
      • Carbon Dioxide Lasers
      • Yttrium Aluminium Garnet Lasers
    • Systems & Parts
      • Instrument Delivery systems
      • Vacuums & Compressors
      • Cone Beam CT Systems
      • Cast Machine
      • Furnace and Ovens
      • Electrosurgical Equipment
      • Other System and Parts
      • CAD/CAM
    • Laboratory Machines
      • Ceramic Furnaces
      • Hydraulic Press
      • Electronic Waxer
      • Suction Unit
      • Micro Motor
    • Hygiene Maintenance Devices
      • Sterilizers
      • Air Purification & Filters
      • Hypodermic Needle Incinerator
    • Other Equipment
      • Chairs
      • Hand Piece
      • Light Cure
      • Scaling Unit

Dental Equipment Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • UK.
    • Germany
    • France
    • Spain
    • Italy
    • Russia
  • Asia Pacific
    • India
    • Japan
    • China
    • Australia
    • South Korea
    • Singapore
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

List of Key Players of Dental Equipment Market

  • A-Dec Inc.
  • Planmeca Oy
  • Dentsply Sirona
  • Patterson Companies Inc.
  • Straumann
  • GC Corporation
  • Carestream Health Inc.
  • Biolase Inc.
  • Danaher Corporation
  • 3M EPSE

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Image-guided Therapy Systems Market is Anticipated to Upgrade USD 5.8 Billion Revenue By 2028: Grand View Research Inc.

 Image-guided Therapy Systems Market Growth & Trends

The global image-guided therapy systems market size is expected to reach USD 5.8 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 6.0% from 2021 to 2028. The growing geriatric population base and increasing cases of chronic diseases are expected to boost the market growth. Other factors propelling the market growth include a rising preference for minimally invasive surgeries and technological advancements in image-guided therapy systems. Various initiatives undertaken in the area of cancer radiotherapy are also driving the market.

New product launches by major companies are also having a positive impact on market growth. For instance, in September 2020, Olympus Corporation launched ENDO-AID, an AI platform and endoscopy application with computer-aided detection for gastrointestinal applications. The AI platform with an endoscopy system-EVIS X1 enables real-time display. The growing adoption of such advanced systems is expected to drive the market. The increasing number of initiatives undertaken by public and private firms in the area of cancer radiotherapy is also estimated to have a positive impact on market growth.

Many academic institutions are also investing in cancer radiotherapy projects for increasing the effectiveness of treatment therapies. This is also likely to contribute to market expansion. The development of the Image-guided Therapy Program by the Brigham and Women’s Hospital aimed at advancing imaging and therapeutic technologies for developing minimally invasive surgical and interventional techniques is an example of one such initiative.

Request a free sample copy or view report summary: Image-guided Therapy Systems Market Report

Image-guided Therapy Systems Market Report Highlights

  • North America accounted for the largest share in 2020 owing to the rising geriatric population and high per capita expenditure
  • By product, the endoscopes segment accounted for the largest revenue share in 2020 owing to technological advancements, a high volume of endoscope-guided surgeries, and the rising preference for minimally invasive surgeries
  • By application, cardiac surgery emerged as the largest application segment in 2020 owing to factors, such as rising incidence of target diseases, increasing preference for minimally invasive cardiac surgeries, and R&D initiatives aimed at developing real-time cardiac intervention systems
  • By end use, the hospitals segment accounted for the largest market share in 2020 as the hospital settings are equipped with technologically advanced devices
  • The ambulatory surgery centers segment is projected to expand at the fastest CAGR of 6.5% over the forecast period

Image-guided Therapy Systems Market Segmentation

Grand View Research has segmented the global image-guided therapy systems market based on product, application, end-use, and region:

Image-guided Therapy Systems Product Outlook (Revenue, USD Million, 2016 - 2028)

  • Ultrasound Systems
  • Computed Tomography (CT) Scanners
  • Positron Emission Tomography (PET)
  • Endoscopes
  • Magnetic Resonance Imaging (MRI)
  • X-ray Fluoroscopy
  • Single Photon Emission Computed Tomography (SPECT)

Image-guided Therapy Systems Application Outlook (Revenue, USD Million, 2016 - 2028)

  • Cardiac Surgery
  • Neurosurgery
  • Orthopedic Surgery
  • Urology
  • Oncology Surgery
  • Gastroenterology
  • Others

Image-guided Therapy Systems End-use Outlook (Revenue, USD Million, 2016 - 2028)

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Research & Academic Institutions

Image-guided Therapy Systems Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • UK.
    • Germany
    • France
    • Italy
    • Spain
    • Sweden
    • Netherlands
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Singapore
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

List of Key Players of Image-guided Therapy Systems Market

  • Koninklijke Philips N.V.
  • Medtronic
  • Siemens Healthineers
  • Analogic Corporation
  • GE Healthcare
  • Varian Medical Systems, Inc.
  • Brainlab AG
  • Olympus Corporation
  • Stryker

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Pharmaceutical Analytical Testing Outsourcing Market Expected to Witness a Sustainable Growth over 2028

 Pharmaceutical Analytical Testing Outsourcing Market Growth & Trends

The global pharmaceutical analytical testing outsourcing market size is expected to reach USD 12.4 billion by 2028 registering a CAGR of 8.3%, according to a new report by Grand View Research, Inc. Increasing pipelines for biological candidates along with rising demand for additional analytical details on drugs as well as process development by regulatory agencies are boosting the market growth. Analytical testing helps in providing real-time product quality control along with optimizing & monitoring processes, characterize biosimilar & biologics, and improving productivity. One of the main reasons for outsourcing analytical testing services is to access skilled & experienced expertise, as well as expensive analytical equipment not available in-house.

Increasing R&D investments is one of the critical sustainability strategies. Not all companies have an infrastructure that is compatible with all types of analytical testing. Hence, outsourcing these operations is the most suitable option, which also helps save time and cost. A patent cliff largely for small molecules with the pharmaceutical industry has led to a huge dent in the pharma’s profits. In the coming years, several best-selling drugs are coming towards the end of patent life including Humira. Drug innovators are under constant pressure to launch new products. Developing advanced analytical testing to assess & monitor the quality attributes of these requires a broader set of equipment & expertise, which is beyond the internal capacity of pharma companies.

The market is developing due to increasing competition in the pharmaceutical and biopharmaceutical markets for disease-specific drugs. Most pharmaceutical manufacturing companies rely on analytical testing to help and improve productivity, optimize and monitor processes, and offer real-time product quality control. Due to this, there is an increasing demand for analytical testing outsourcing services. Hence the market is expected to show lucrative growth over the forecast period. Outsourcing of analytical testing services allows companies to handle more complex activities and focus on their core competencies. This offers cost savings by letting medical companies evade building specialized facilities and hiring staff. Pharmaceutical analytical testing includes the identification and quantification of components in therapeutic solutions or drugs.

The nature of Covid-19 transmission has led several laboratory staff members to face uncertainties, such as fears of contracting the infection along with other biosafety concerns. Thus, reduced manpower and increasing focus on the development of vaccines & therapies against Covid-19 are anticipated to negatively impact the turnaround time for routine tests. The large number of R&D activities, clinical trials, and diagnostic procedures being conducted to counteract Covid-19 is anticipated to increase the demand for analytical testing services since several pharmaceutical companies are now focusing on their core competencies and outsourcing non-core functions to increase their productivity & operational efficiency.

Request a free sample copy or view report summary: Pharmaceutical Analytical Testing Outsourcing Market Report

Pharmaceutical Analytical Testing Outsourcing Market Report Highlights

  • The bioanalytical testing segment led the global market in 2020 accounting for the largest revenue share due to the high number of clinical trial registrations and entry of new participants within the market space
  • The segment is also expected to register the fastest CAGR over the forecast period owing to growing R&D expenditure by pharmaceutical companies and preference for outsourcing bioanalytical testing
  • The extractable and leachable services in the method development and validation segment is expected to dominate the market and register the fastest CAGR owing to an increasing number of vendors offering these services at competitive prices
  • Asia Pacific is anticipated to be the fastest-growing regional market from 2021 to 2028 due to low-cost service offering by the third-party service providers in the region

Pharmaceutical Analytical Testing Outsourcing Market Segmentation

Grand View Research has segmented the global pharmaceutical analytical testing outsourcing market on the basis of service and region:

Pharmaceutical Analytical Testing Outsourcing Service Outlook (Revenue, USD Million, 2016 - 2028)

  • Bioanalytical
    • Clinical
    • Non-clinical
  • Method Development & Validation
    • Extractable & Leachable
    • Impurity Method
    • Technical Consulting
    • Others
  • Stability Testing
    • Drug Substance
    • Stability Indicating Method Validation
    • Accelerated Stability Testing
    • Photostability Testing
    • Others
  • Others

Pharmaceutical Analytical Testing Outsourcing Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • UK.
    • Germany
    • France
    • Italy
    • Spain
    • Russia
    • Turkey
    • The Netherlands
    • Switzerland
    • Sweden
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Indonesia
    • Malaysia
    • Singapore
    • Thailand
    • Taiwan
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Chile
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Israel

List of Key Players of Pharmaceutical Analytical Testing Outsourcing Market

  • SGS SA
  • Toxikon, Inc.
  • Eurofins Scientific
  • Pace Analytical Services, Inc.
  • Intertek Group Plc
  • Pharmaceutical Product Development, LLC.
  • WuXi AppTec, Inc.
  • Boston Analytical
  • Charles River Laboratories International, Inc.
  • West Pharmaceutical Services Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Tuesday, 19 January 2021

Demand Medical Affairs Outsourcing Market Increasing in Most Part of World 2028

 Medical Affairs Outsourcing Market Growth & Trends

The global medical affairs outsourcing market size is expected to reach USD 3.47 billion by 2028 registering a CAGR of 12.2%, according to a new report by Grand View Research, Inc. Transformation in medical education and the rising number of orphan therapies for the treatment of rare diseases are some of the key factors propelling the market growth. The pharmaceutical companies are looking for assistance to systematically position the therapeutic outcomes of these therapies in the market. According to a report published by IQVIA in 2020, the U.S. FDA has approved 80 orphan indications in 2017 and about 57 in early 2020.

Changes in the reimbursement scenario and pricing pressure are expected to increase the adoption of cost-saving measures by the pharmaceutical and medical device companies. This is anticipated to promote off-shoring of medical affairs outsourcing in countries like India and China. Pharmaceutical companies are outsourcing medical affairs services to get high-quality documents, control the R&D cost, and reduce investment costs required to train the medical affairs team. Furthermore, the pharmaceutical and medical device companies are outsourcing their medical affairs services to diverge their business activities and manage product life cycles.

In addition, Contract Research Organizations (CROs) offer cost-efficient solutions and compliance with the health authority requirements, thereby propelling market growth. The bio/pharmaceutical outsourcing industry has seen a rise in R&D demand because of the COVID-19 pandemic. This increase in demand, as well as other impacts from the pandemic, such as rising demand for clinical trials and its outsourcing services, have caused some CROs to shift focus and adjust their operations. The pandemic has pushed more pharmaceutical companies and regulators to use new technologies for remote quality audits and inspections, thus driving positive changes in the pharma industry.

Request a free sample copy or view report summary: Medical Affairs Outsourcing Market Report

Medical Affairs Outsourcing Market Report Highlights

  • The medical writing & publishing segment led the market in 2020 and is expected to witness significant growth over the forecast period, owing to the increasing need for marketable written content to convey medical information to healthcare professionals and patients
  • North America dominated the global market with a share of 35.3% in 2020 owing to the presence of a large number of pharmaceutical and medical devices companies in the region
  • Moreover, the high cost of medical affairs services is a major challenge, which has encouraged various medical device companies in North America to outsource functions to third-party vendors in off-shore locations with a high level of expertise in the domain
  • However, Asia Pacific is anticipated to account for the largest revenue share by 2028 while growing at the fastest CAGR over the forecast period, owing to cost-efficient service offering by the CROs in the region
  • In addition, improved regulatory framework and availability of a skilled workforce in APAC boosts the market growth

Medical Affairs Outsourcing Market Segmentation

Grand View Research has segmented the global medical affairs outsourcing market on the basis of services, industry, and region:

Medical Affairs Outsourcing Services Outlook (Revenue, USD Billion, 2016 - 2028)

  • Medical Writing & Publishing
  • Medical Monitoring
  • Medical Science Liaisons (MSLs)
  • Medical Information
  • Others

Medical Affairs Outsourcing Industry Outlook (Revenue, USD Billion, 2016 - 2028)

  • Pharmaceutical
  • Biopharmaceutical
  • Medical Devices
    • Therapeutic Medical Devices
    • Diagnostic Medical Devices

Medical Affairs Outsourcing Regional Outlook (Revenue, USD Billion, 2016 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • UK.
    • Germany
    • France
    • Italy
    • Spain
  • Asia Pacific
    • Japan
    • China
    • India
    • Korea
    • Australia
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

List of Key Players of Medical Affairs Outsourcing Market

  • ICON plc
  • IQVIA Holdings, Inc.
  • The Medical Affairs Company
  • Syneos Health, Inc.
  • Pharmaceutical Product Development, LLC
  • Ashfield Healthcare Communications
  • Zeincro Group
  • Wuxi Clinical Development, Inc.
  • SGS S.A.
  • Indegene, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Clinical Trials Market Witness Excellent Revenue Growth During 2021-2028: Grand View Research Inc

 Clinical Trials Market Growth & Trends

The global clinical trials market size is expected to reach USD 69.5 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.7% from 2021 to 2028. An increase in the volume and complexity of clinical trials has been witnessed lately, which plays an important role in the R&D of new drugs and other products. Also, clinical studies have become increasingly costly ventures, adding to the overall cost of developing a drug. Hence, big pharmaceuticals as well as small biotechnology firms are looking for innovative ways to improve research outcomes and decrease research costs.

The increasing need to develop new therapeutics for chronic diseases such as cancer, respiratory disorder, diabetes, cardiovascular disease, and others is creating immense pressure on healthcare. The global pandemic caused due to COVID-19 and the increasing demand for developing a suitable treatment for the same is driving the market’s growth. The number of people affected by the coronavirus has reached one million, which further depicts an increasing need for therapeutics and vaccines. Currently, there are 288 therapeutics and 106 vaccines in development. Out of this, nearly 7.0% therapeutics are in Phase IV, 21.0% in Phase III, 43.0% & 13.0% in Phase II & Phase I respectively.

The pandemic has also resulted in global disruption of traditional onsite clinical studies. Hence, the regulatory bodies all over the world have launched various initiatives for fast-tracking clinical studies for the development of innovative solutions. One such instance is Solidarity, an international clinical trial launched by the WHO to find effective treatment against COVID-19.

Though COVID-19 is forcing many medical device and drug developers to revise the approach they prepare for these types of crises, integrating best practices within clinical trial procedures and adapting to virtual studies can support continuous development of therapeutics even in the presence of this pandemic.

Request a free sample copy or view report summary: Clinical Trials Market Report

Clinical Trials Market Report Highlights

  • Phase III clinical trials dominated the market with a share of 53.2% in 2020. This is attributed to the complexity level associated with this phase
  • Interventional design segment accounted for the largest share of 45.6% in 2020 in the study design segment owing to the increasing demand for the intervention for clinical studies by researchers
  • North America held 51.0% of the market share in 2020. Favorable government initiatives and presence of large numbers of players in the U.S. offerings advanced services are responsible for market growth
  • In Asia Pacific, the market is expected to witness the fastest CAGR of 6.7% over the forecast period owing to the increasing patient pool and cost efficient services

Clinical Trials Market Segmentation

Grand View Research has segmented the global clinical trials market based on phase, study design, indication, and region:

Clinical Trials Phase Outlook (Revenue, USD Million, 2016 - 2028)

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Clinical Trials Study Design Outlook (Revenue, USD Million, 2016 - 2028)

  • Interventional
  • Observational
  • Expanded Access

Clinical Trials Indication Outlook (Revenue, USD Million, 2016 - 2028)

  • Autoimmune/Inflammation
  • Pain management
  • Oncology
  • CNS condition
  • Diabetes
  • Obesity
  • Cardiovascular
  • Others

Clinical Trials Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • UK.
    • Germany
    • France
    • Spain
    • Italy
  • Asia Pacific
    • India
    • Japan
    • China
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

List of Key Players of Clinical Trials Market

  • IQVIA
  • PAREXEL International Corporation
  • Pharmaceutical Product Development, LLC
  • Charles River Laboratory
  • ICON Plc
  • PRA Health Sciences
  • Syneos Health
  • Eli Lilly and Company
  • Novo Nordisk A/S
  • Pfizer
  • Clinipace

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Fetal Monitoring Equipment Market is Thriving $6.16 Billion Revenue by 2030: Grand View Research Inc.

  Fetal Monitoring Equipment Market Growth & Trends The global  fetal monitoring equipment market  size is anticipated to reach USD 6.16...